Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

Amphastar Pharmaceuticals, Inc. Earnings Per Share (Basic)

Amphastar Pharmaceuticals, Inc. (AMPH) reported Earnings Per Share (Basic) of $0.69 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-08-06

  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.69, a 4.55% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.14, a 73.58% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.53, a 32.76% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.38, a 54.22% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was $2.10, a 36.17% decline from fiscal 2024.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was $3.29, a 15.44% increase from fiscal 2023.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was $2.85, a 51.60% increase from fiscal 2022.
  • Amphastar Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was $1.88, a 44.62% increase from fiscal 2021.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30$0.69
10-Q · filed 2026-08-06
$0.83
10-Q · filed 2026-08-06
$1.36
derived: net income ÷ weighted average shares · filed 2026-08-06
$1.73
derived: net income ÷ weighted average shares · filed 2026-08-06
2026-03-31$0.14
10-Q · filed 2026-05-07
$0.68
derived: net income ÷ weighted average shares · filed 2026-08-06
$1.05
derived: net income ÷ weighted average shares · filed 2026-08-06
$1.72
derived: net income ÷ weighted average shares · filed 2026-08-06
2025-12-31$0.53
derived: net income ÷ weighted average shares · filed 2026-04-13
$0.90
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.57
derived: net income ÷ weighted average shares · filed 2026-08-06
$2.10
10-K · filed 2026-02-26
2025-09-30$0.38
10-Q · filed 2025-11-06
$1.04
derived: net income ÷ weighted average shares · filed 2026-08-06
$1.57
10-Q · filed 2025-11-06
$2.36
derived: net income ÷ weighted average shares · filed 2026-08-06
2025-06-30$0.66
10-Q · filed 2026-08-06
$1.19
10-Q · filed 2026-08-06
$1.98
derived: net income ÷ weighted average shares · filed 2026-08-06
$2.82
derived: net income ÷ weighted average shares · filed 2026-08-06
2025-03-31$0.53
10-Q · filed 2026-05-07
$1.32
derived: net income ÷ weighted average shares · filed 2026-08-06
$2.16
derived: net income ÷ weighted average shares · filed 2026-08-06
$2.93
derived: net income ÷ weighted average shares · filed 2026-08-06
2024-12-31$0.79
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.62
derived: net income ÷ weighted average shares · filed 2026-04-13
$2.40
derived: net income ÷ weighted average shares · filed 2026-04-13
$3.29
10-K · filed 2026-02-26
2024-09-30$0.83
10-Q · filed 2025-11-06
$1.61
derived: net income ÷ weighted average shares · filed 2025-11-06
$2.50
10-Q · filed 2025-11-06
$3.26
derived: net income ÷ weighted average shares · filed 2026-04-13
2024-06-30$0.77
10-Q · filed 2025-08-07
$1.67
10-Q · filed 2025-08-07
$2.43
derived: net income ÷ weighted average shares · filed 2026-04-13
$3.44
derived: net income ÷ weighted average shares · filed 2026-04-13
2024-03-31$0.90
10-Q · filed 2025-05-08
$1.65
derived: net income ÷ weighted average shares · filed 2026-04-13
$2.66
derived: net income ÷ weighted average shares · filed 2026-04-13
$3.20
derived: net income ÷ weighted average shares · filed 2026-04-13
2023-12-31$0.75
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.77
derived: net income ÷ weighted average shares · filed 2026-04-13
$2.31
derived: net income ÷ weighted average shares · filed 2026-04-13
$2.85
10-K · filed 2026-02-26
2023-09-30$1.01
10-Q · filed 2024-11-07
$1.55
derived: net income ÷ weighted average shares · filed 2024-11-07
$2.10
10-Q · filed 2024-11-07
$2.80
derived: net income ÷ weighted average shares · filed 2026-04-13
2023-06-30$0.54
10-Q · filed 2024-08-09
$1.08
10-Q · filed 2024-08-09
$1.78
derived: net income ÷ weighted average shares · filed 2026-04-13
$2.11
derived: net income ÷ weighted average shares · filed 2026-04-13
2023-03-31$0.54
10-Q · filed 2024-05-10
$1.24
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.57
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.92
derived: net income ÷ weighted average shares · filed 2026-04-13
2022-12-31$0.70
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.02
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.38
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.88
10-K · filed 2025-03-03
2022-09-30$0.32
10-Q · filed 2023-11-08
$0.68
derived: net income ÷ weighted average shares · filed 2023-11-08
$1.18
10-Q · filed 2023-11-08
$1.59
derived: net income ÷ weighted average shares · filed 2026-04-13
2022-06-30$0.35
10-Q · filed 2023-08-09
$0.86
10-Q · filed 2023-08-09
$1.27
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.89
derived: net income ÷ weighted average shares · filed 2026-04-13
2022-03-31$0.50
10-Q · filed 2023-05-09
$0.92
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.53
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.70
derived: net income ÷ weighted average shares · filed 2026-04-13
2021-12-31$0.41
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.03
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.19
derived: net income ÷ weighted average shares · filed 2026-04-13
$1.30
10-K · filed 2024-02-29
2021-09-30$0.62
10-Q · filed 2022-11-08
$0.78
derived: net income ÷ weighted average shares · filed 2022-11-08
$0.89
10-Q · filed 2022-11-08
$0.76
derived: net income ÷ weighted average shares · filed 2023-03-01
2021-06-30$0.16
10-Q · filed 2022-08-09
$0.27
10-Q · filed 2022-08-09
$0.14
derived: net income ÷ weighted average shares · filed 2023-03-01
$0.22
derived: net income ÷ weighted average shares · filed 2023-03-01
2021-03-31$0.11
10-Q · filed 2022-05-10
-$0.03
derived: net income ÷ weighted average shares · filed 2023-03-01
$0.06
derived: net income ÷ weighted average shares · filed 2023-03-01
$0.05
derived: net income ÷ weighted average shares · filed 2023-03-01
2020-12-31-$0.13
derived: net income ÷ weighted average shares · filed 2023-03-01
-$0.05
derived: net income ÷ weighted average shares · filed 2023-03-01
-$0.05
derived: net income ÷ weighted average shares · filed 2023-03-01
$0.03
10-K · filed 2023-03-01
2020-09-30$0.08
10-Q · filed 2021-11-09
$0.08
derived: net income ÷ weighted average shares · filed 2021-11-09
$0.16
10-Q · filed 2021-11-09
$0.14
derived: net income ÷ weighted average shares · filed 2021-11-09
2020-06-30$0.00
10-Q · filed 2021-08-09
$0.08
10-Q · filed 2021-08-09
$0.06
derived: net income ÷ weighted average shares · filed 2021-11-09
$0.09
derived: net income ÷ weighted average shares · filed 2021-11-09
2020-03-31$0.09
10-Q · filed 2021-05-07
$0.06
derived: net income ÷ weighted average shares · filed 2021-11-09
$0.09
derived: net income ÷ weighted average shares · filed 2021-11-09
$1.11
derived: net income ÷ weighted average shares · filed 2021-11-09
2019-12-31-$0.02
10-K · filed 2020-03-16
$0.01
derived: net income ÷ weighted average shares · filed 2020-11-06
$1.02
derived: net income ÷ weighted average shares · filed 2020-11-06
$1.04
10-K · filed 2022-03-11
2019-09-30$0.03
10-Q · filed 2020-11-06
$1.04
derived: net income ÷ weighted average shares · filed 2020-11-06
$1.06
10-Q · filed 2020-11-06
$1.11
derived: net income ÷ weighted average shares · filed 2020-11-06
2019-06-30$1.01
10-Q · filed 2020-08-07
$1.04
10-Q · filed 2020-08-07
$1.08
derived: net income ÷ weighted average shares · filed 2020-11-06
$1.14
derived: net income ÷ weighted average shares · filed 2020-11-06
2019-03-31$0.02
10-Q · filed 2020-05-11
$0.06
derived: net income ÷ weighted average shares · filed 2020-11-06
$0.11
derived: net income ÷ weighted average shares · filed 2020-11-06
$0.05
derived: net income ÷ weighted average shares · filed 2020-11-06
2018-12-31$0.04
10-K · filed 2020-03-16
$0.09
derived: net income ÷ weighted average shares · filed 2020-03-16
$0.03
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.12
10-K · filed 2021-03-15
2018-09-30$0.05
10-K · filed 2020-03-16
-$0.01
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.16
10-Q · filed 2019-11-08
-$0.13
derived: net income ÷ weighted average shares · filed 2020-03-16
2018-06-30-$0.06
10-K · filed 2020-03-16
-$0.21
10-Q · filed 2019-08-09
-$0.22
10-Q · filed 2018-08-09
-$0.18
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.18
derived: net income ÷ weighted average shares · filed 2020-03-16
2018-03-31-$0.15
10-K · filed 2020-03-16
-$0.16
10-Q · filed 2018-05-10
-$0.12
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.12
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.08
derived: net income ÷ weighted average shares · filed 2020-03-16
2017-12-31$0.02
10-K · filed 2019-03-15
$0.03
10-K · filed 2018-03-14
$0.03
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.08
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.08
10-K · filed 2020-03-16
$0.10
10-K · filed 2018-03-14
2017-09-30$0.00
10-K · filed 2019-03-15
$0.04
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.06
10-Q · filed 2018-11-09
$0.07
10-Q · filed 2017-11-09
$0.00
derived: net income ÷ weighted average shares · filed 2019-03-15
2017-06-30$0.04
10-K · filed 2019-03-15
$0.06
10-Q · filed 2018-08-09
$0.00
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.09
derived: net income ÷ weighted average shares · filed 2019-03-15
2017-03-31$0.02
10-K · filed 2019-03-15
-$0.04
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.04
derived: net income ÷ weighted average shares · filed 2019-03-15
$0.20
derived: net income ÷ weighted average shares · filed 2019-03-15
2016-12-31-$0.06
10-K · filed 2018-03-14
$0.03
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.18
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.22
10-K · filed 2019-03-15
$0.23
10-K · filed 2017-03-15
2016-09-30$0.09
10-K · filed 2018-03-14
$0.24
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.29
10-Q · filed 2017-11-09
$0.46
derived: net income ÷ weighted average shares · filed 2018-03-14
2016-06-30$0.15
10-K · filed 2018-03-14
$0.21
10-Q · filed 2017-08-09
$0.38
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.31
derived: net income ÷ weighted average shares · filed 2018-03-14
2016-03-31$0.06
10-K · filed 2018-03-14
$0.22
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.16
derived: net income ÷ weighted average shares · filed 2018-03-14
$0.01
derived: net income ÷ weighted average shares · filed 2018-03-14
2015-12-31$0.17
10-K · filed 2017-03-15
$0.10
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.05
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.06
10-K · filed 2018-03-14
2015-09-30-$0.07
10-K · filed 2017-03-15
-$0.21
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.23
10-Q · filed 2016-11-09
-$0.38
derived: net income ÷ weighted average shares · filed 2017-03-15
2015-06-30-$0.15
10-K · filed 2017-03-15
-$0.16
10-Q · filed 2016-08-09
-$0.33
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.68
derived: net income ÷ weighted average shares · filed 2017-03-15
2015-03-31-$0.01
10-K · filed 2017-03-15
-$0.14
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.57
derived: net income ÷ weighted average shares · filed 2017-03-15
-$0.87
derived: net income ÷ weighted average shares · filed 2017-03-15
2014-12-31-$0.06
10-K · filed 2016-03-15
-$176.95
derived: net income ÷ weighted average shares · filed 2016-03-15
-$211.07
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.25
10-K · filed 2017-03-15
2014-09-30-$0.12
10-K · filed 2016-03-15
-$155.41
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.20
10-Q · filed 2015-11-13
-$0.65
derived: net income ÷ weighted average shares · filed 2016-03-15
2014-06-30-$0.03
10-K · filed 2016-03-15
-$0.07
10-Q · filed 2015-08-13
-$0.07
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.06
derived: net income ÷ weighted average shares · filed 2016-03-15
2014-03-31-$0.04
10-K · filed 2016-03-15
$0.01
derived: net income ÷ weighted average shares · filed 2016-03-15
$0.00
derived: net income ÷ weighted average shares · filed 2016-03-15
$0.27
derived: net income ÷ weighted average shares · filed 2016-03-15
2013-12-31$0.05
10-K · filed 2015-03-26
$0.04
derived: net income ÷ weighted average shares · filed 2015-03-26
$0.24
derived: net income ÷ weighted average shares · filed 2015-03-26
$0.31
10-K · filed 2016-03-15
2013-09-30$0.00
10-K · filed 2015-03-26
$0.20
derived: net income ÷ weighted average shares · filed 2015-03-26
$0.26
10-Q · filed 2014-11-13
2013-06-30$0.20
10-K · filed 2015-03-26
$0.26
10-Q · filed 2014-08-13
2013-03-31$0.06
10-K · filed 2015-03-26
2012-12-31$0.47
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87